Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-08-28
1992-04-14
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514913, 514869, 514363, 514326, 536 41, 424435, C07D27762, C07D27768, C07D27776, A61K 31425
Patent
active
051048876
ABSTRACT:
High potency carbonic anhydrase inhibitors derived from methazolamide.
REFERENCES:
patent: 4029776 (1977-06-01), Cafruny et al.
patent: 4476140 (1984-10-01), Sears et al.
patent: 4619939 (1986-10-01), Maren
patent: 4746745 (1988-05-01), Maren
patent: 4758578 (1988-07-01), Tegeler et al.
patent: 4985450 (1991-01-01), Tegeler et al.
patent: 5055480 (1991-10-01), Pierce, Jr.
DeBenedetti et al., "Chem Abstract"; vol. 108(15); p. 127395m; 1987.
Barfknecht Charles F.
Schoenwald Ronald D.
Griffin Ronald W.
Leary Louise
University of Iowa Research Foundation
LandOfFree
Topical ophthalmic imino substituted 2-imino-3-methyl-delta4-1,3 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Topical ophthalmic imino substituted 2-imino-3-methyl-delta4-1,3, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topical ophthalmic imino substituted 2-imino-3-methyl-delta4-1,3 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2349573